Key Events This Week
2 Feb: Stock hits 52-week low at Rs.1,245.15 amid underperformance
3 Feb: New 52-week low of Rs.1,238.30 despite marginal intraday gains
4 Feb: Further decline to 52-week low of Rs.1,230.05 on weak sector performance
5 Feb: Fresh 52-week low at Rs.1,216.20 amid rising interest expenses
6 Feb: Stock rebounds 2.70% to close at Rs.1,250.10, still below week open

Jupiter Life Line Hospitals Ltd Falls to 52-Week Low of Rs.1216.2
2026-02-05 09:47:06Jupiter Life Line Hospitals Ltd has declined to a fresh 52-week low of Rs.1216.2, marking a significant downturn in its stock price amid broader market fluctuations and company-specific performance factors.
Read full news article
Jupiter Life Line Hospitals Ltd Falls to 52-Week Low of Rs.1230.05
2026-02-04 10:31:00Jupiter Life Line Hospitals Ltd has touched a new 52-week low of Rs.1230.05 today, marking a significant decline in its share price amid broader market fluctuations and sectoral underperformance. The stock’s fall to this level reflects a continuation of its subdued trend over the past year, contrasting with the relatively stronger performance of the benchmark indices.
Read full news article
Jupiter Life Line Hospitals Ltd Falls to 52-Week Low of Rs.1230.05
2026-02-04 10:30:56Jupiter Life Line Hospitals Ltd has touched a new 52-week low of Rs.1230.05 today, marking a significant decline in its stock price amid broader market fluctuations and sector-specific pressures. The stock underperformed its hospital sector peers and the broader market indices, reflecting ongoing concerns about its recent financial performance and valuation metrics.
Read full news article
Jupiter Life Line Hospitals Ltd Falls to 52-Week Low of Rs.1238.3
2026-02-03 14:17:25Jupiter Life Line Hospitals Ltd’s share price declined to a fresh 52-week low of Rs.1238.3 today, marking a significant milestone in the stock’s recent performance. This new low reflects ongoing pressures on the company’s valuation amid broader market dynamics and sector-specific factors.
Read full news article
Jupiter Life Line Hospitals Ltd Falls to 52-Week Low Amidst Underperformance
2026-02-02 13:50:35Jupiter Life Line Hospitals Ltd has touched a new 52-week low of Rs.1245.15 today, marking a significant decline in its share price amid broader market fluctuations. The stock has underperformed its sector and key benchmarks, reflecting ongoing concerns about its recent financial performance and valuation metrics.
Read full news article
Jupiter Life Line Hospitals Ltd Valuation Shifts to Fair Amidst Market Pressure
2026-02-02 08:03:59Jupiter Life Line Hospitals Ltd has experienced a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade amid a deteriorating market outlook. Despite solid operational metrics, the stock has seen a decline in price and a downgrade in its overall mojo rating, reflecting growing investor caution in the hospital sector.
Read full news article
Jupiter Life Line Hospitals Ltd is Rated Sell
2026-02-01 10:10:39Jupiter Life Line Hospitals Ltd is rated Sell by MarketsMOJO. This rating was last updated on 17 Dec 2025, reflecting a shift from the previous Hold rating. However, the analysis and financial metrics discussed here represent the stock’s current position as of 01 February 2026, providing investors with the latest insights into its performance and outlook.
Read full news articleAre Jupiter Life Line Hospitals Ltd latest results good or bad?
2026-01-31 19:30:11Jupiter Life Line Hospitals Ltd's latest financial results for Q2 FY26 indicate a company that has demonstrated operational strength, achieving a net profit of ₹57.35 crores, which reflects a significant quarter-on-quarter growth of 30.67%. The revenue for the quarter reached ₹393.63 crores, marking an 11.53% increase from the previous quarter and a 17.48% rise year-on-year. This performance highlights the company's ability to scale operations effectively while maintaining margin discipline, as evidenced by an operating margin of 23.44%, which is an improvement from the prior quarter. However, the subsequent quarter's results for December 2025 show a different trend, with net sales experiencing a decline of 7.18% compared to the previous quarter, and net profit decreasing by 25.81%. This shift raises questions about the sustainability of the growth observed in the earlier quarter. The company's operation...
Read full news article





